RxDoctor Payments Data

John Huber, MD

Dermatopathology · Memphis, TNNPI 1760459069

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 657 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 27.2% of the total. Reporting peaked in 2023 at $2,340 and has fallen 50.1% since, to $1,168 in 2025. Among dermatopathology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,041in general payments, 2019–2025

Across 657 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novartis$1K
  • Merz North America, Inc.$861
  • Pfizer$750
  • Johnson & Johnson$654
  • Sanofi$527
  • plus $4K from 25 others

What the payments were for

  • Food & beverage$10,95699%
  • Education$851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,041 in reported general payments places this provider in the 95th percentile of 20 dermatopathology providers in Tennessee.

See all dermatopathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$416,900
Medicare patients
796
Services billed
3,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus45$8,772
Clobetasol Propionate113$5,634
Doxycycline Hyclate393$4,017
Betamethasone Dipropionate79$3,289
Metronidazole25$2,736
Triamcinolone Acetonide96$1,811
Ketoconazole136$1,795
Fluorouracil23$1,648
Finasteride75$941
Clindamycin Phosphate17$872
Terbinafine Hcl39$761
ValacyclovirValacyclovir Hcl30$638
Fluconazole59$621
Minoxidil33$539
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc11$529

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →